The Seattle Times

4 of 7
JOHN LOK / THE SEATTLE TIMES
Advertising

Wednesday, February 8, 2012

Seattle's Sage Bionetworks seeks a drug-discovery revolution

Why do some cancer patients respond to chemo while others don't? It's in the DNA, says oncologist Jerald Radich. He's working on a unique project with Sage to study the DNA of these "nonresponders."